These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24831092)

  • 21. Plant-based vaccines against viruses.
    Rybicki EP
    Virol J; 2014 Dec; 11():205. PubMed ID: 25465382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacology and viral infections.
    Reynolds KS
    Clin Pharmacol Ther; 2010 Nov; 88(5):569-73. PubMed ID: 20959836
    [No Abstract]   [Full Text] [Related]  

  • 23. [Progess in the development of VLPs vaccine].
    Cao L; Bi SL
    Bing Du Xue Bao; 2011 Jul; 27(4):378-82. PubMed ID: 21874909
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.
    Alexander-Miller MA
    J Immunol; 2014 Dec; 193(11):5363-9. PubMed ID: 25411431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biotechnology for the benefit of vaccination against viral diseases: a review].
    van Oirschot JT
    Tijdschr Diergeneeskd; 2002 Jan; 127(1):7-16. PubMed ID: 11795035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory Antibodies Targeting Emerging Viruses: Advancements and Mechanisms.
    Jin J; Simmons G
    Clin Vaccine Immunol; 2016 Jul; 23(7):535-9. PubMed ID: 27226280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Basic requirements of viral vaccines and methods for their control].
    Osidse DF
    Arch Exp Veterinarmed; 1980; 34(1):123-6. PubMed ID: 6774690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial overview: Virus reverse genetics approaches for the development of preventive and therapeutic vaccines.
    Martinez-Sobrido L; Nogales A
    Curr Opin Virol; 2020 Oct; 44():iii-iv. PubMed ID: 33349418
    [No Abstract]   [Full Text] [Related]  

  • 29. Emerging viruses and current strategies for vaccine intervention.
    Afrough B; Dowall S; Hewson R
    Clin Exp Immunol; 2019 May; 196(2):157-166. PubMed ID: 30993690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Progress in virus-like particles technique studies].
    Guo JQ; Zhang ZQ
    Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):167-73. PubMed ID: 20077665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arenaviral vaccine vectors to combat infectious diseases.
    Dhanwani R; Ly H
    Oncotarget; 2016 Jul; 7(29):44875. PubMed ID: 27391429
    [No Abstract]   [Full Text] [Related]  

  • 32. Virus-like particles in vaccine development.
    Roldão A; Mellado MC; Castilho LR; Carrondo MJ; Alves PM
    Expert Rev Vaccines; 2010 Oct; 9(10):1149-76. PubMed ID: 20923267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA vaccines for viral infections: basic studies and applications.
    Robinson HL; Pertmer TM
    Adv Virus Res; 2000; 55():1-74. PubMed ID: 11050940
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.
    Bowick GC; McAuley AJ
    Bioeng Bugs; 2011; 2(3):129-35. PubMed ID: 21637006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination strategies.
    Woodland DL
    Viral Immunol; 2008 Mar; 21(1):1-2. PubMed ID: 18355117
    [No Abstract]   [Full Text] [Related]  

  • 36. Invasive diseases: new vaccines and vaccination strategies.
    Crovari P
    J Prev Med Hyg; 2012 Jun; 53(2):49. PubMed ID: 23240159
    [No Abstract]   [Full Text] [Related]  

  • 37. The application of virus-like particles to human diseases.
    Buonaguro F; Buonaguro L
    Expert Rev Vaccines; 2013 Feb; 12(2):99. PubMed ID: 23414399
    [No Abstract]   [Full Text] [Related]  

  • 38. New approaches in viral vaccine development.
    Brown F
    Scand J Infect Dis Suppl; 1990; 76():39-46. PubMed ID: 1966307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunity to viruses: learning from successful human vaccines.
    Pulendran B; Oh JZ; Nakaya HI; Ravindran R; Kazmin DA
    Immunol Rev; 2013 Sep; 255(1):243-55. PubMed ID: 23947360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress in respiratory virus vaccine development.
    Schmidt AC
    Semin Respir Crit Care Med; 2007 Apr; 28(2):243-52. PubMed ID: 17458777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.